Behandling av opioid abstinens

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 2, 2009, Pages 114-115

  Shaygani, Shahram ^a   Waal, Helge ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC AGENT;

ARTICLE; HUMAN; OPIATE ADDICTION; SOCIAL SUPPORT; WITHDRAWAL SYNDROME;

BUPRENORPHINE; HUMANS; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; SOCIAL SUPPORT; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 59249091993     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.32466     Document Type: Article

References (10)

1. Amato L, Davoli M, Minozzi S et al. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev 2005; nr 3: CD003409.
2. Gowing L, Ali R, White J. Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 2002; nr 2: CD002021.
3. Gowing L, Ali R, White J. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 2006; nr 2: CD002025.
4. Gowing L, Ali R, White J. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database Syst Rev 2006; nr 2: CD002022.
5. Gowing L, Ali R, White J. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database Syst Rev 2006; nr 1: CD002021.
6. Lintzeris N, Clark N, Mühleisen P et al. National Clinical Guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence. National Drug Strategy. Canberra: Department of Health and Aged Care, 2001.
7. National Institute of Health and Clinical Excellence. NICE clinical guideline 52. Drug misuse: opioid detoxification. Rapport nr. 52. London: National Institute of Health and Clinical Excellence, 2007.
8. Statens beredning för medicinsk utvärdering. Behandling av alkohol- och narkotikaproblem: en evidensbaserad kunnskapssammanställning. Stockholm: SBU, 2001.
9. Vanedannende legemidler - forskrivning og forsvarlighet. IK 2755. Oslo: Statens helsetilsyn 2001.
10. Gowing LR, Ali RL. The place of detoxification in treatment of opioid dependence. Curr Opin Psychiatry 2006; 19: 266-70.